1. Rudebeck M, Scott C, Rhodes NP, Van Kan C, Olsson B, Al-sbou M, et al. Clinical development innovation in rare diseases: lessons learned and best practices from the DevelopAKUre consortium. Orphanet J Rare Dis. 2021;16:510.
2. Rare Disease Act 2002. Public Law 107-280–Nov. 6, 2022. Available at: https://www.congress.gov/107/plaws/publ280/PLAW-107publ280.pdf.
3. Global Genes. RARE disease facts [Internet]. Aliso Viejo: Global Genes. Available from: https://globalgenes.org/rare-disease-facts/. Accessed 01 Aug 2022.
4. Clark J, Muhlemann N, Natanegara F, Hartley A, Wenkert D, Wang F, et al. Why are not there more Bayesian clinical trials? Perceived barriers and educational preferences among medical researchers involved in drug development. Ther Innov Regul Sci. 2022;3:1–9.
5. Kidwell KM, Roychoudhury S, Wendelberger B, Scott J, Moroz T, Yin S, Majumder M, Zhong J, Huml RA, Miller V. Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdles. Orphanet J Rare Dis. 2022;17(1):1–5.